5 Signs Your COPD Treatment Isn’t Working
The trick is finding the right treatment plan for you. “COPD can come in a few different varieties. Some people have just ...
FiercePharma10h
Verona touts 'exceptionally strong' launch of blockbuster hopeful COPD treatment Ohtuvayre
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
Monthly Prescribing Reference1d
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...
2minutemedicine.com4h
Different single inhaler triple therapies appear to have similar clinical outcomes for chronic obstructive pulmonary disease
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
pharmaphorum13h
Verona says COPD drug is off to a flying start
Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start," with more than 3,500 healthcare ...
News Medical on MSN1d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
BBC1mon
First new asthma attack treatment in 50 years
"But it’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years," she said. Plans for an upgraded NHS app to allow more patients in England ...